about
Medication review in hospitalised patients to reduce morbidity and mortalityIndustry sponsorship and research outcomeIndustry sponsorship and research outcomeConflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort studyAdequacy of authors' replies to criticism raised in electronic letters to the editor: cohort studyRecommendations by Cochrane Review Groups for assessment of the risk of bias in studies.Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.Industry sponsorship and research outcome.Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.Sponsors' participation in conduct and reporting of industry trials: a descriptive study.Quality of systematic reviews in pediatric oncology--a systematic review.Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study.[Is there an evidence for screening for depression?].Access to data in industry-sponsored trials.[Region uses medication reviews despite weak evidence].The ties that bind.Under-reporting of conflicts of interest among trialists: a cross-sectional study.[Emergency department X-rays requested by physicians or nurses].International or national publication of case reports.Correction: Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study.Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authorsThe Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort StudyIndustry sponsorship and research outcome: systematic review with meta-analysis[Sponsorship of continuing medical education][The rheumatologists' conflict of interest and biological medicines]Income from reprints creates a conflict of interestsWas the composite outcome specified in the original protocol?Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficiallyWhat to do with a clinical trial with conflicts of interestOne-way SMS and healthcare outcomes in Africa: Systematic review of randomised trials with meta-analysisFinancial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological qualityUse of professional profiles in applications for specialist training positions
P50
Q24200610-7C5EEEB2-059F-42A6-88A0-AF76F6561E73Q24202591-A2D55B63-F264-464E-80FD-95F83F3C45D2Q24234843-E8E83374-1DC0-41CA-BC18-B30FC128F3FFQ28475928-893C6EE2-0531-4CE4-A102-403BDB8F3173Q28749806-DB71E0CE-E53D-4C7C-98FF-200DF3528436Q33329705-424841D7-6A81-4171-9E8F-E9FF8961FA4CQ33710440-86520A69-1E01-4F3F-B2F3-5DEB0078D098Q34116483-3C381C75-D8FE-4875-B1B3-B476D465258DQ34551400-47A88B2E-4D20-435F-86A8-61942EE83F23Q34705062-99B4229C-2A91-4C27-83D8-2B74B3D214A6Q36412743-F3E31366-BEB0-4C0D-AAAB-9818EB0A32A1Q37616610-BD89A9C5-2C11-4A97-8ACF-919CB970F2CBQ38811335-6D0335CB-4A7C-465E-A82F-F5B8FA65BCBFQ40300339-B8127BB4-59DC-4C19-B03E-940A8197EEE2Q44312806-C07F393E-E3B2-4BF5-88DF-D566AD5C136BQ44851057-90D9C8D6-BDE1-4E55-84CB-2AAA605312BEQ46235628-0B8D1559-E13B-409D-9B76-71C0ED6623CBQ47589346-F73B911D-B2DD-47D2-9F99-F087EFCC6919Q51793018-4F9396A1-6321-45A4-8AA3-906A36F9A4ADQ53060190-E89C1CE2-0047-4579-B292-0B6513798DADQ53159363-DE837C99-949C-44E9-B9D8-3087E45746C5Q54996491-1F3C0138-24E2-45D0-BF73-DA18AEBF9878Q57034678-2D1D463F-C640-4E9E-9E7F-6D2551091256Q63727309-095DC85B-9C59-4A6C-931A-E4C74BFF5799Q64122695-503F853D-8C10-47D0-AA20-095FD31C0E91Q81525967-EAFA31E2-A3A9-47C8-ADCF-A51A100C2AC0Q82592608-2E25B329-65E1-47FF-ACC9-2275FEC43CF6Q84608441-2569F94F-1DAB-4163-A91D-80C078F08B29Q85602380-0408CAC7-362B-4864-9E77-A2D0A04E4F3EQ91758889-2981772F-9B5C-4017-8A74-14CD979B9796Q91775559-71B5CD1C-2E38-4D45-BA78-5E9344A1D2B5Q92562269-0152E155-C2A8-4D1D-B3D8-35772DC075EDQ92698203-661DB3C9-005B-4ED1-B8BD-B59D2B6C299CQ95366825-A7407471-15E3-4198-98D6-B94B0A4868DD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Lundh
@af
Andreas Lundh
@an
Andreas Lundh
@ast
Andreas Lundh
@ay
Andreas Lundh
@az
Andreas Lundh
@br
Andreas Lundh
@ca
Andreas Lundh
@ce
Andreas Lundh
@ceb
Andreas Lundh
@co
type
label
Andreas Lundh
@af
Andreas Lundh
@an
Andreas Lundh
@ast
Andreas Lundh
@ay
Andreas Lundh
@az
Andreas Lundh
@br
Andreas Lundh
@ca
Andreas Lundh
@ce
Andreas Lundh
@ceb
Andreas Lundh
@co
altLabel
Andreas Hover Lundh
@af
Andreas Hover Lundh
@an
Andreas Hover Lundh
@ast
Andreas Hover Lundh
@ay
Andreas Hover Lundh
@az
Andreas Hover Lundh
@br
Andreas Hover Lundh
@ca
Andreas Hover Lundh
@ce
Andreas Hover Lundh
@ceb
Andreas Hover Lundh
@co
prefLabel
Andreas Lundh
@af
Andreas Lundh
@an
Andreas Lundh
@ast
Andreas Lundh
@ay
Andreas Lundh
@az
Andreas Lundh
@br
Andreas Lundh
@ca
Andreas Lundh
@ce
Andreas Lundh
@ceb
Andreas Lundh
@co
P106
P1153
24178937800
P21
P31
P496
0000-0002-4982-8680
P569
2000-01-01T00:00:00Z